The next board meeting for Tscan Therapeutics Inc is on 30 Jun 2025 for the purpose of TScan Therapeutics Inc Annual General Meeting for 2025See details
Tscan Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of 108.5%, and profit growth estimate of -15.6% for FY25, based on top 8 analyst calls.